Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation

A. Ilvan, E. Kunter, E. Demirer, K. Avsar, Z. Kartaloglu, M. Oztosun (Istanbul, Turkey)

Source: Annual Congress 2005 - COPD - exacerbations I
Session: COPD - exacerbations I
Session type: Thematic Poster Session
Number: 1900
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ilvan, E. Kunter, E. Demirer, K. Avsar, Z. Kartaloglu, M. Oztosun (Istanbul, Turkey). Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation. Eur Respir J 2005; 26: Suppl. 49, 1900

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Serum leptin levels in patients with chronic airway diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002

Effect of corticosteroid therapy upon serum magnesium level in chronic asthmatic children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010

Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Plasma biomarkers and response to therapy at exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 39s
Year: 2007

Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Serum leptin levels in asthmatic children treated with inhaled corticosteroid
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004

Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 141s
Year: 2002

The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002

Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012

Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021
Year: 2022



Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002